Abstract
We studied the quality of life of obesity hypoventilation syndrome (OHS) by comparing it with age- and body mass index-matched patients without hypoventilation and age-matched obstructive sleep apnea (OSA) patients with body mass index (BMI) under 30, and the efficacy of nasal continuous positive airway pressure (CPAP) therapy for 3 to 6 months on the quality of life in these patients. Prospectively recruited patients from six sleep laboratories in Japan were administered assessments of the general health status by the Short-Form 36 Health Survey (SF-36) and subjective sleepiness by the Epworth Sleepiness Scale (ESS). Compared with matched healthy subjects, OHS and OSA patients not yet treated had worse results on the ESS scores and the SF-36 subscales for physical functioning, role limitations due to physical problems, general health perception, energy/vitality, role limitations due to emotional problems, and social functioning. The ESS scores of OHS patients were worse than those of the OSA groups including the age- and BMI-matched OSA patients. In the SF-36 subscales of OHS patients, only the subscale of social functioning showed worse results compared with that of BMI-matched OSA patients. After 3 to 6 months of treatment, ESS scores and these SF-36 subscales in all three patient groups improved to the normal level. These results suggested that the quality of life of OHS before nasal CPAP was significantly impaired and that nasal CPAP for OHS improved the quality of life associated with the improvement of daytime sleepiness to the level of the other OSA patients.
Similar content being viewed by others
References
Burwell CS, Robin ED, Whaley RD, Bickelmann AG. Extreme obesity associated with alveolar hypoventilation—a Pickwickian syndrome. Am J Med 1956;21:811–818
Subramanian S, StrohlKP. A management guideline for obesity-hypoventilation syndromes. Sleep Breathing 1999;3:131–138
Kuriyama T, Akashiba T, Ishihara E, et al. Guideline for diagnosis and management of obesity hypoventilation syndrome and primary alveolar hypoventilation syndrome. Research reports for respiratory failure by Respiratory Failure Research Committee in Japanese Ministry of Health and Welfare [in Japanese]. 2002:137–162
McNamara SG, Grunstein RR, Sullivan CE. Obstructive sleep apnoea. Thorax 1993;48:754–764
Smith IE, Shneerson JM. Is the SF-36 sensitive to sleep disruption? A study in subjects with sleep apnoea. J Sleep Res 1995;4:183–188
Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med 1998;158:494–503
Bennett LS, Barbour C, Langford B, StradlingJR, Davies RJO. Health status in obstructive sleep apnea. Relationship with sleep fragmentation and daytime sleepiness, and effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med 1999;159:1884–1890
Flemons WW, Reimer MA. Measurement properties of the Calgary Sleep Apnea Quality of Life Index. Am J Respir Crit Care Med 2002;165:159–164
Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000;16:118–122
Sullivan CE, Issa FG, Berthorn-Jones N. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862–865
Kiely JL, Murphy M, McNicholasWT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J 1999;13:1086–1090
Engelman HM, Cheshire KE, Deary IJ. Daytime sleepiness, cognitive performance and mood after CPAP therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1993;48:911–914
Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med 2000;94:87–90
Tun Y, Hida W, Okabe S, et al. Inspiratory effort sensation to added resistive loading in patients with obstructive sleep apnea. Chest 2000;118:1332–1338
Engelman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572–575
Taguchi O, Hida W, Okabe S, et al. Improvement of exercise performance with short-term nasal continuous positive airway pressure in patients with obstructive sleep apnea. Tohoku J Exp Med 1997;183:45–53
Lamphere J, Roehrs T, Wittig R. Recovery of alertness after CPAP in sleep apnea. Chest 1989;96:1364–1367
Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473–483
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540–545
Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 1998;51:1037–1044
Guilleminault C, Tilkian A, DementWC. The sleep apnea syndromes. Annu Rev Med 1976;27:465–484
Rechtschaffen A, Kales A. A Manual of Standardized Terminology; Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute; 1968
Tun Y, Hida W, Okabe S, et al. Effects of nasal continuous positive airway pressure on awake ventilatory responses to hypoxia and hypercapnia in patients with obstructive sleep apnea. Tohoku J Exp Med 2000;190:157–168
Lopata M, Freilich RA, OnalE. Ventilatory control and the obesity hypoventilation syndrome. Am Rev Respir Dis 1979;119:165–168
Rochester DF, Enson Y. Current concepts in the pathogenesis of OHS. Mechanical and circulatory factors. Am J Med 1974;57:402–420
Han F, Chen E, Wei H, He Q, Ding D, StrohlKP. Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2001;119:1814–1819
Phipps PR, Starritt E, Caterson I, GrunsteinRR. Association of serum leptin with hypoventilation in human obesity. Thorax 2002;57:75–76
O’Donnell CP, Schaub CD, Haines AS, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999;159:1477–1484
Martin SE, Wraith PK, Deary IJ, et al. The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med 1997;155:1596–1601
Gislason T, Almqvist M, Boman G, et al. Increased CSF opioid activity in sleep apnea syndrome: regression after successful treatment. Chest 1989;96:250–254
Briones B, Adams N, Strauss M, et al. Relationship between sleepiness and general health status. Sleep 1996;19:583–588
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hida, W., Okabe, S., Tatsumi, K. et al. Nasal Continuous Positive Airway Pressure Improves Quality of Life in Obesity Hypoventilation Syndrome. Sleep Breath 7, 3–12 (2003). https://doi.org/10.1007/s11325-003-0003-1
Issue Date:
DOI: https://doi.org/10.1007/s11325-003-0003-1